Share on

Global DNA Sequencing Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product & Services, Technology, Workflow, Application, End User, and Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa) - Industry Forecast (2022 to 2027).

Published: January, 2022
ID: 10636
Pages: 190
Formats: report pdf report excel report power bi report ppt

Global DNA Sequencing Market Size (2022 to 2027)

The global DNA sequencing market size is forecasted to hike at a CAGR of 14.2% from 2022 to 2027. This market is estimated to be worth USD 11.14 billion by 2027 and USD 5.73 billion in 2022.

The DNA sequence is used to identify the structure of a DNA molecule in laboratories. Researchers will require this information to identify a DNA molecule's genetic data and understand its function in the body.

Impact of COVID-19 on the DNA sequencing market:

The COVID-19 pandemic had a favorable effect on the DNA sequencing market under investigation because it raised interest in DNA sequencing technology for developing treatments and diagnostics. For instance, the FDA granted an Emergency Use Authorization (EUA) for the Helix COVID-19 NGS test in August 2020. This test is an amplicon-based next-generation sequencing (NGS) test designed for the qualitative detection of SARS-CoV-2 nucleic acid in upper respiratory specimens from people suspected of having COVID-19 infection. Therefore, the market is expected to maintain its high growth rate over the forecast period due to the growing DNA sequencing-based research and development activities in developing diagnostic tools or efficient therapies for COVID-19.

MARKET DRIVERS:

The global DNA sequencing market is majorly driven by its high accuracy rate/speed rate.

DNA sequencing over the microarray and other genomic analysis methods offers accurate results from low sample input. The discovery of DNA variants has been made possible by rapid developments in bioinformatics and sequencing technologies. These developments also identify variations linked to a higher risk of disease. In addition, the efficacy of DNA sequencing in clinical diagnosis applications is increased by the widespread use of Next-generation sequencing (NGS) and whole-genome sequencing (WGS), which allow several genes to be examined simultaneously on a single diagnostic platform.

From 2D sequencing in the 1970s to DNA sequencing, sequencing technology has advanced significantly. Platforms like Illumina/ Solexa, ABI/ SOLiD, 454/Roche, and Helicos have recently opened up possibilities for high-throughput functional genomics research. Furthermore, biologists and informatics professionals have been concentrating on creating better genomes, which have been made feasible by newer sequencing technologies, unique ways of finding chromosome sequences and enhanced DNA sequencing software.

In addition, the DNA sequencing market's cost-effective nature is also favoring the market's growth rate. As a result, DNA sequencing can be used for various applications such as drug discovery, oncology studies, personalized medicine, forensics, biomarkers, etc. Furthermore, factors such as a surge in sequencing applications, growing R&D investments, the increase in the numerous genome mapping programs, and technological advancements are also fuelling the growth of the global DNA sequencing market.

MARKET RESTRAINTS:

The global DNA sequencing market is constrained by factors such as expensive equipment, computational difficulties, repetition content, specialist skills, and ethical concerns.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

Based on the Product & Services, Technology, Workflow, Application, End User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global DNA sequencing market has been segmented and sub-segmented based on the product & services, technology, workflow, application, end-user, and region.

DNA Sequencing Market – By Product & Services:

  • Consumables
  • Instruments
  • Services

Based on the product & services, the consumables segment accounted for the largest share of 39.4% of the global DNA sequencing market in 2021. The consumables segment has a wide range of kits and reagents for all library construction steps, such as enrichment, adapter ligation, quality control, and DNA fragmentation.

The services segment is favored by high-performance accuracy, high experiment team assists, and advanced technology. During the forecast period, the highest CAGR is expected to register by the services segment due to the rapid turnaround time, support from the technical side, and outstanding customer services.

DNA Sequencing Market – By Technology:

  • Sanger Sequencing
  • Next-Generation Sequencing
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Targeted Sequencing & Resequencing
  • Third Generation DNA Sequencing  
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing

Based on the technology, the NGS segment accounted for a significant share of the global DNA sequencing market in 2021, owing to the factors such as expanding NGS applications, speed, cost, accuracy, efficient replacement of conventional technologies, and drug discovery applications requiring NGS technology are driving the next-generation sequencing market. This technique is substantially cheaper, faster, and uses significantly less DNA, all of which contribute to the segment's total growth. In addition, since the COVID-19 pandemic, next-generation sequencing technology has become more widely employed in infection diagnosis due to its great efficiency and accuracy.

Nanopore and single-molecule real-time sequencing are various third-generation sequencing methods and other lucrative segments in this market. Rapid usage of third-generation DNA sequencing with a comparison of second-generation techniques by including easy sample preparations helps these segments make a stand.

DNA Sequencing Market – By Workflow:

  • Pre-sequencing
  • Sequencing
  • Data Analysis

Based on the workflow, the primary phase of the entire workflow, sequencing had the highest revenue share in the DNA sequencing market in 2021. This process makes it possible to profile the genome's sequence and analyze DNA-protein interactions. It contributes more because it is a crucial component of the complete DNA sequencing workflow in research and discovery activities. Understanding of human health and disease therapies is accelerated by sequencers' capacity to produce a significant amount of data in a short length of time.

During the forecast period, the data analysis segment is estimated to register the fastest CAGR due to the generation of substantial profits to run already existing genomics software, reduce prices, and create new data centers. Moreover, the advancement of technology will further help to analyze massive processes. These factors are attributed to the largest share in the Data Analysis segment.

DNA Sequencing Market – By Application:

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agri-genomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Consumer Genomics
  • Others

Based on the application, the oncology segment dominated the DNA sequencing market in 2021 with 25.6%. This segment has enormous potential for clinical research and the creation of cancer treatments and diagnostics. Recent advancements in NGS technology have shown its potential as a high-throughput, low-cost method for quickly identifying and characterizing therapeutically useful genetic variations across a wide range of genes in a single test.

The quickest growing segment is consumer genomics which is expected to register the highest growth rate during the forecast period. Genealogy, personal health awareness, ancestry, and paternity testing are parts of rapid proliferation. Biotechnology companies like Helix Opto LLC and AncestryDNA are some factors attributing to the consumer genomics segment in the forecast period.

DNA Sequencing Market – By End-use:

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users

Based on the end-user, due to the widespread use of sanger technology and NGS in academic and institutional research initiatives, the academic research segment dominated the market for DNA sequencing in 2021.

DNA Sequencing Market – By Region:

  • North America
    • The United States
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of EU
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Chile
    • Rest of Latin America
  • Middle East and Africa

Among all the regions, the North American DNA sequencing market accounted for the leading global market share in 2021 and is expected to continue dominating the market during the forecast period. The rise in the prevalence of cancer, the growing geriatric population, and the development of innovation ecology favor the North American market. Moreover, major market key players in this region and large buying power are further fueling the market to grow further. In addition, because of increased funding and support operations by government and non-government organizations, particularly in the United States, North America dominated the market.

The DNA sequencing market in the U.S. is growing at a significant rate. The key driving forces for DNA sequencing in the U.S. are the rising usage of modern technologies and favorable government backing and related legislation. In addition, the rise of the COVID-19 pandemic has had a favorable impact on market growth. For example, Genome Canada established the Canadian COVID Genomics Network (CanCOGeN) in April 2020, a newly founded effort sponsored by USD 40 million in financing. CanCOGeN, led by Genome Canada, will scale up genomics-based research in collaboration with the six regional Genome Centers, national and provincial public health labs, genome sequencing centers through CGEn, hospitals, universities, and the corporate sector.

The European DNA sequencing market was the second leading region globally in 2019 and is predicted to register a robust CAGR between 2020 to 2025. The rise in the aging population and the increase in the patient's count suffering from cancer, sedentary lifestyle, and efficient reimbursement scenarios are expected to favor the European market growth.

Due to many patients, the Asia-pacific DNA sequencing market is predicted to hike significantly during the forecast period. Moreover, improving healthcare infrastructure and increasing healthcare expenditure in this region is a big plus to the global market.

The Latin America DNA sequencing market is predicted to showcase a healthy CAGR during the forecast period.

As expected, the lowest share was contributed by the MEA DNA sequencing market to the global market in 2021. Some hampers are a shortage of advanced technologies and poor medical facilities.

KEY MARKET PLAYERS:

Agilent Technologies, Inc., Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG, PerkinElmer Inc., and Thermo Fisher Scientific, Inc. are some of the companies dominating the global DNA sequencing market.

KEY HAPPENINGS IN THIS MARKET:

  • In August 2020, NovaSeq 6000 v1.5 Reagent Kit was launched by Illumina Inc. that kit was made for the WGS technique with high cost-effectiveness. This is accessed to all laboratories and also helps to reduce costs.
  • In August 2020, an FDA provision was made for the first liquid biopsy companion diagnostic by leveraging NGS technology to guide cancer treatment.
  • In April 2020, EUA was received from Helix OpCo LLC for the Helix COVID-19 NGS Test to detect SARS-CoV-2 infection.

Please wait. . . . Your request is being processed

FAQ's

How much is the global DNA sequencing market going to be worth by 2027?

The global market size for DNA sequencing is predicted to be worth USD 11.14 billion by 2027.

 

Which region is growing the fastest in the global DNA sequencing market?

Geographically, the APAC DNA sequencing market is estimated to showcase the fastest CAGR in the global market during the forecast period.

Who are the key players in the global DNA sequencing market?

Companies playing a key role in the global DNA sequencing market are Agilent Technologies, Inc., Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG, PerkinElmer Inc., and Thermo Fisher Scientific, Inc.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample